STAAR SURGICAL CO · Ophthalmic Goods

STAA

High riskNext report: Due any day

View price ↗

The short version

A company still losing money with growing sales. Institutions are adding.

Going well

Sales up 111% in the latest quarter vs a year ago
No debt reported

Watch out for

Losing money, losses are large next to sales
Revenue down 23.7% from the year before

Money moves

No insider buying or selling in the last 30 days
Institutions added 2.6% to their holdings in the quarter ending June 2026 (106 bought, 87 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$23.20+2.6% that day

Company value: $1.2B; Share price times all shares
Price vs profit (P/E): 290.0x; You pay about $290 for each $1 of yearly profit
Price vs sales: 3.4x; Company value is 3.4 times a year of sales
Cash vs value: 13%; Cash as a share of company value

From STAA's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jul '26

$93.5M+111% vs a year earlier

Sep '23Tap a barJul '26

Last 12 months: $339.6M, up 51% from the 12 months before. Over 5 years, sales grew about 7.9% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of STAA. Starting points are the company's recent numbers.

Sales growth+30% a yearRecently: +51% a yearProfit margin1%Last 12 months: 1.1%P/E at the end40xToday: 290.0x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$1.3B

Profit in 5 years$13M

Price these guesses point to$10.06-57% vs $23.20 todayAbout -15% a year, before dividends

What today's price needs: with a 1% margin and a 40x P/E, sales would have to grow about 54% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/7Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-21.7%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-33.6%
MissProfitable every yearSteady profits, not one good year.6 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$40.0M
PassShare count not growingNot diluting owners. Falling means buybacks.+0.4% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.76.2%

Revenue: $239.4M; -23.7% vs prior year
5-year growth: +7.9%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 4.55x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.